IndiaTickerLatest filing: Astec Lifesciences Ltd - 533138 - Announcement under Regulation 30 (LODR)-Newspaper Publication
ObservedCompany dossier
Astec Lifesciences
NSE:ASTEC · ISIN INE563J01010
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Astec Lifesciences
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹93.9 Cr · PAT ₹-40.4 Cr.
Exchange XBRLLatest ownership: promoter group 71.96% and public 28.04% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Astec LifeSciences Limited: Ratings reaffirmed
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing Astec Lifesciences Ltd - 533138 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · financial results
Observed
Source filing Astec Lifesciences Ltd - 533138 - Board Meeting Outcome for Outcome Of Board Meeting
BSE · exchange filing
Observed
Source filing Astec Lifesciences Ltd - 533138 - Financial Result For The Quarter Ended June 30, 2026
BSE · financial results
Observed
Source filing Astec Lifesciences Ltd - 533138 - Shareholder Meeting / Postal Ballot-Outcome of AGM
BSE · annual report
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹93.9 Cr
- Profit after tax
- ₹-40.4 Cr
- EPS
- ₹-20.59
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 71.96%
- Public
- 28.04%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL